| 1. | I have reviewed this Quarterly      Report on Form 10-Q of Oncolin Therapeutics,  Inc.; |
|----|-----------------------------------------------------------------------------------------|

| 2. | Based on my knowledge, this report      does not contain any untrue statement of a material fact or omit to state      a material fact necessary to make the statements made, in light of the      circumstances under which such statements were made, not misleading with      respect to the period covered by this  report; |
|----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 3. | Based on my  knowledge,      the financial statements, and other financial information included in this      report, fairly present in all material respects the financial condition,      results of operations and cash flows of the small business issuer as of,      and for, the periods presented in this  report; |
|----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 4. | I am responsible for establishing      and maintaining disclosure controls and procedures (as defined in Exchange      Act Rules 13a-15(e) and 15d-15(e)) for the small business issuer and      have: |
|----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 5. | I have disclosed, based on, my      most recent evaluation of internal control over financial reporting to the      small business issuer's auditors and the audit committee of the small      business issuer's board of directors (or persons performing the equivalent      functions): |
|----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | a) | All significant deficiencies and      material weaknesses in the design or operation of internal control over      financial reporting which are reasonably likely to adversely affect the      small business issuer's ability to record, process, summarize and report      financial information; and |
|--------|----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | b) | Any fraud, whether or not      material, that involves management or other employees who have a      significant role in the small business issuer's internal control over      financial reporting. |
|--------|----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| By:    | /s/ J. Leonard      Ivins    |   |
|--------|------------------------------|--------|
|   | J. Leonard      Ivins        |   |
|   | Chief Executive      Officer |   |

----